Related content

Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 203-206

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing

By Bassanello M.   Vitale A.   Ciarleglio F.A.   Brolese A.   Zanus G.   D'Amico F.   Carraro A.   Cappuzzo G.   Bridda A.   Senzolo M.   Burra P.   Pevere S.   D'Amico D.   Cillo U.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 2991-2994

Elsevier

Access to resources Recommend Favorite

Comparative study of survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma

By Figueras J.   Ramos E.   Ibanez L.   Rafecas A.   Fabregat J.   Torras J.   Lama C.   Ruiz D.   Moreno G.   Arteche N.   Jaurrieta E.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2487-2488

Elsevier

Access to resources Recommend Favorite

Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1028-1034

Spandidos Publications

Access to resources Recommend Favorite

Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib

By Takeda   Nishikawa   Iguchi   Ohara   Sakamoto   Hatamaru   Henmi   Saito   Nasu   Komekado   Kita   Kimura   Osaki  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 241-248

Spandidos Publications

Access to resources Recommend Favorite